reports
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Te...
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Composition" developed within this platform. The Laetose™ technology demonstrates compelling potential in reducing caloric intake and ...
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market Chairman of the Board Heng Fai Ambrose Chan Adds 672,173 Shares to Increase Investment in Company NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating across four distinct market sectors, announced today a significant investment by its Chairman of the Board, Heng Fai Ambrose Chan. In a strategic move to bolster shareholder confidence and underscore his commitment to the company’s growth. Chairman Chan acquired an additional 672,173 shares of DS, Inc. ...
DSS Inc: 2 directors
Two Directors at DSS Inc bought/sold 823,193 shares at between 0.131USD and 0.146USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance ...
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority shareholders to eff...
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Con...
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years Option for Fourth Year Brings Potential Revenue to Over $15 Million NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, , signed a contract extension with an existing client for the next t...
DSS Inc. Wins Patent Dispute with Nichia Corporation
DSS Inc. Wins Patent Dispute with Nichia Corporation NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that, in a unanimous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.'s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges Kara Stoll and Tiffany Cunningham sat on the panel for the Federal Circuit. The CAFC appeal mounted by Nichia Corp., a Japanese electronics company, asserted that a 2021 Inter Partes Review ...
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Rever...
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock DSS Shareholders to Benefit from Reduction in Common Stock of Impact Biomedical NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that Impact BioMedical Inc. (“Impact”) filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for ...
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading ...
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule Company intends to cure the deficiency and return to compliance with NYSE American standard NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) announced today that the Company received a letter (the “Letter”) from the staff of NYSE American LLC (the “Exchange”) stating that the Company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The Company’s continued li...
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for I...
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of the Company's wholly-owned subsidiary, Impact Biomedical (hyperlink: /). DSS, Inc. intends to list Impact Biomedical on the NYSE American exchange. The number of shares of Class A common stock to be offered and the pric...
DSS Inc. Issues Letter to Shareholders
DSS Inc. Issues Letter to Shareholders CEO Highlights Expected IPO of Impact Biomedical and Progress in Subsidiaries ROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders, On behalf of the management team at DSS, Inc., I am pleased to provide an update on our progress so far this year and o...
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ram...
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed Income ROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has joined as Chief Operating Officer and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role o...
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of ...
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc. DSS Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. ROCHESTER, N.Y., July 31, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs to shareholders, announced today the distribution date for the previously announced stock dividend of Impact...
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio...
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc. ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) -- DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as Chief Investment Officer and Portfolio Manager. With over three decades of experience in investment management, security analysis, and institutional client advisory, Mr. Lew brings a wealth of knowledge and expertise to his new role. Mr. Lew's distinguished career spans various...
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of I...
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc. Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. on a Future Distribution Date ROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend of Impact Biomedical In...
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical...
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS Share ROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14, 2023. DSS shar...
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 3...
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 ROCHESTER, N.Y., May 16, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, announced today its financial results for the First Quarter, 2023. Selected Financial Highlights Premier Packaging revenue increased 72% - Revenue from sales of printed products increased 72% during the 3 months ended March 31, 2023, as compared to ...
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS...
DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders Distribution Date of May 4, 2023 Set for Stock Dividend of Sharing Services Shares (SHRG) ROCHESTER, N.Y., May 01, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, announced today the distribution date for the common stock of Sharing Services Global Corporation (“Sharing Services” or “SHRG”) that is beneficially hel...
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Service...
DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders First of Several Planned Dividends to DSS Shareholders ROCHESTER, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, announced that the Company plans to distribute to its stockholders common stock of Sharing Services Global Corporation (“Sharing Services” or “SHRG”) that is benef...
DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM
DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM Company to Highlight Strong Revenue Growth and Planned Spinoffs to DSS Shareholders ROCHESTER, N.Y., April 17, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses in diversified market sectors and strategically acquiring and developing assets to increase shareholder value through periodic IPO spinoffs, announced today that Jason Grady, Chief Operating Officer of DSS, will be presenting at the Emerging Growth Virtual Conference on Wednesday, April 19 from 1:45-2:15 PM....
DSS Announces Letter to Shareholders
DSS Announces Letter to Shareholders CEO Highlights Business Plan including Spin-Offs ROCHESTER, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to enrich shareholder value, today announced a letter to shareholders. Dear Shareholders: I want to begin by thanking you, our shareholders, for your continued support as we execute our vision of a decentralized sharing business model to build shareholder value and drive exponentia...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.